WR Wealth Planners LLC Lowers Stake in UnitedHealth Group Incorporated (NYSE:UNH)

WR Wealth Planners LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.0% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,315 shares of the healthcare conglomerate’s stock after selling 317 shares during the quarter. WR Wealth Planners LLC’s holdings in UnitedHealth Group were worth $1,171,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of UNH. M&T Bank Corp increased its position in UnitedHealth Group by 13.4% in the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock worth $128,975,000 after purchasing an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC increased its position in UnitedHealth Group by 17.6% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after purchasing an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. increased its position in UnitedHealth Group by 1,275.3% in the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after purchasing an additional 41,308 shares during the last quarter. Parsifal Capital Management LP bought a new stake in UnitedHealth Group in the third quarter worth $21,165,000. Finally, Signal Advisors Wealth LLC increased its position in UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after purchasing an additional 1,051 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of analyst reports. KeyCorp reiterated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a report on Friday, January 10th. Truist Financial lowered their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Piper Sandler lowered their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Finally, Barclays lowered their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Trading Up 1.4 %

NYSE UNH opened at $474.95 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a market capitalization of $437.09 billion, a price-to-earnings ratio of 30.64, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company’s 50-day simple moving average is $516.59 and its two-hundred day simple moving average is $557.16. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the firm posted $5.83 EPS. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.77%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s payout ratio is currently 54.19%.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.